What is Avalo Therapeutics's total revenue?

Avalo Therapeutics (AVTX) reported total revenue of $59K in Q4 2025.

How has Avalo Therapeutics's total revenue changed year-over-year?

Avalo Therapeutics's total revenue decreased by 69.3% year-over-year, from $192K to $59K.

What is the long-term trend for Avalo Therapeutics's total revenue?

Over 3 years (2021 to 2024), Avalo Therapeutics's total revenue has grown at a -56.6% compound annual growth rate (CAGR), from $5.4M to $441K.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Avalo Therapeutics AVTX Total Revenue

Discontinued — last reported Q4 '25

Total Revenue at other companies

Eli LillyLLY

$19.8B+55.5%

AbbVieABBV

$15B+12.4%

Aclaris TherapeuticsACRS

$2M+37.2%

XencorXNCR

$4.52M-86.2%

Shattuck Labs, Inc.STTK

$0—

AnaptysBio, Inc.ANAB

$25.56M-8.0%

Other financials

Income statement

See full

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$946.18M+1,783%

Enterprise value$921.19M-1,342%

P/S1,892.4×+1,852×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Avalo Therapeutics’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's total revenue?: Avalo Therapeutics (AVTX) reported total revenue of $59K in Q4 2025.
How has Avalo Therapeutics's total revenue changed year-over-year?: Avalo Therapeutics's total revenue decreased by 69.3% year-over-year, from $192K to $59K.
What is the long-term trend for Avalo Therapeutics's total revenue?: Over 3 years (2021 to 2024), Avalo Therapeutics's total revenue has grown at a -56.6% compound annual growth rate (CAGR), from $5.4M to $441K.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.